Your search found 1 Results
AVSC NEWS. 1998 Spring; 36(1):3, 8.With the average woman in Jordan bearing 4-5 children during her reproductive lifetime, Jordan's population is growing rapidly. Many contraceptive methods are available through Jordan's well-developed health care system, but the public is aware of only a few, and misinformation is common. The government of Jordan launched a study, sponsored by AVSC and Family Health International (FHI), to determine the feasibility of introducing Norplant implants and Depo-Provera, in an effort to increase the choice, knowledge, availability, and use of contraceptive methods. More than 300 clients who received Norplant implant or Depo-Provera services at three health care facilities in Amman were followed. Many of the women chose either of these two methods because of their desire to delay pregnancy for a long time, often 5 years or more. Most cited length of protection, ease of use, dissatisfaction with previously used methods, and fewer perceived side effects than other methods as reasons for choosing either Norplant or Depo-Provera. The quality of counseling varied among the three facilities. At the end of 6 months follow-up, about 80% of the Norplant users and one-third of the Depo-Provera users reported being very satisfied with the method and planned to continue using it. However, although most clients experienced at least one side effect during the first 6 months of use, such effects were cited as the main reason for method discontinuation. Discontinuation of Depo-Provera was also influenced by popular attitudes and outside decision-makers such as health care providers, counselors, husbands, and other family members. Study results were presented at a workshop held in Amman in fall 1997.